A correlative study of gliomas using in vivo bromodeoxyuridine labeling index and computer-aided malignancy grading

Suash Sharma, Asis K. Karak, Rajvir Singh, V. S. Mehta, Chitra Sarkar, Horst P. Schmitt

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

An in vivo bromodeoxyuridine (BrdU) labeling index (LI) was estimated in 43 cases of astrocytic tumors and mixed gliomas by one hour intra-operative intravenous infusion at a dose of 200 mg/m 2 and correlated with (a) histological grading using a computer aided malignancy classifier TESTAST- 268; and (b) histological typing using WHO classification. The lowest BrdU LI was seen in pilocytic and gemistocytic astrocytomas followed by astrocytomas, anaplastic astrocytomas and glioblastoma multiforme in that order. Mixed oligoastrocytomas followed the pattern of their astrocytic counterparts. Tumors of similar histological type showed different BrdU LI values especially amongst astrocytomas and glioblastomas. A statistically significant difference in the BrdU LI was also noted between the higher TESTAST grades of astrocytomas (T III and IV) versus the lower TESTAST grades (T II). Unlike earlier reports in literature, in the present study the category of BrdU LI of <1 contained no case of anaplastic astrocytoma or glioblastoma multiforme (TESTAST grades III and IV). Likewise, the category of BrdU LI >5 contained only anaplastic astrocytoma and glioblastoma multiforme (TESTAST grades III and IV). Maximum spread of cases was seen in the BrdU LI category of 1-5, not only in terms of histological types but also TESTAST grades. Thus there appeared to be a positive trend of increasing BrdU LI values both with histological types and increasing TESTAST grades. Further, an interesting observation was that by using a combination of TESTAST grades and BrdU LI, the histologically homogenous glioblastoma group could be further subdivided into 4 categories which showed a trend towards prognostic correlation. Thus, this study though preliminary with number of cases being small in some groups, highlights the possible usefulness of combined histological typing, TESTAST grading and in vivo BrdU LI for prognostication of gliomas especially glioblastoma multiforme.

Original languageEnglish (US)
Pages (from-to)134-141
Number of pages8
JournalPathology and Oncology Research
Volume5
Issue number2
DOIs
StatePublished - Jan 1 1999
Externally publishedYes

Fingerprint

Astrocytoma
Bromodeoxyuridine
Glioma
Glioblastoma
Neoplasms
Intravenous Infusions
Observation

Keywords

  • Computer aided grading
  • Gliomas
  • Histologic grading
  • In vivo BrdU LI
  • Malignancy classification

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Oncology
  • Cancer Research

Cite this

A correlative study of gliomas using in vivo bromodeoxyuridine labeling index and computer-aided malignancy grading. / Sharma, Suash; Karak, Asis K.; Singh, Rajvir; Mehta, V. S.; Sarkar, Chitra; Schmitt, Horst P.

In: Pathology and Oncology Research, Vol. 5, No. 2, 01.01.1999, p. 134-141.

Research output: Contribution to journalArticle

Sharma, Suash ; Karak, Asis K. ; Singh, Rajvir ; Mehta, V. S. ; Sarkar, Chitra ; Schmitt, Horst P. / A correlative study of gliomas using in vivo bromodeoxyuridine labeling index and computer-aided malignancy grading. In: Pathology and Oncology Research. 1999 ; Vol. 5, No. 2. pp. 134-141.
@article{20c7e927107b4445b99e88f28f12e76e,
title = "A correlative study of gliomas using in vivo bromodeoxyuridine labeling index and computer-aided malignancy grading",
abstract = "An in vivo bromodeoxyuridine (BrdU) labeling index (LI) was estimated in 43 cases of astrocytic tumors and mixed gliomas by one hour intra-operative intravenous infusion at a dose of 200 mg/m 2 and correlated with (a) histological grading using a computer aided malignancy classifier TESTAST- 268; and (b) histological typing using WHO classification. The lowest BrdU LI was seen in pilocytic and gemistocytic astrocytomas followed by astrocytomas, anaplastic astrocytomas and glioblastoma multiforme in that order. Mixed oligoastrocytomas followed the pattern of their astrocytic counterparts. Tumors of similar histological type showed different BrdU LI values especially amongst astrocytomas and glioblastomas. A statistically significant difference in the BrdU LI was also noted between the higher TESTAST grades of astrocytomas (T III and IV) versus the lower TESTAST grades (T II). Unlike earlier reports in literature, in the present study the category of BrdU LI of <1 contained no case of anaplastic astrocytoma or glioblastoma multiforme (TESTAST grades III and IV). Likewise, the category of BrdU LI >5 contained only anaplastic astrocytoma and glioblastoma multiforme (TESTAST grades III and IV). Maximum spread of cases was seen in the BrdU LI category of 1-5, not only in terms of histological types but also TESTAST grades. Thus there appeared to be a positive trend of increasing BrdU LI values both with histological types and increasing TESTAST grades. Further, an interesting observation was that by using a combination of TESTAST grades and BrdU LI, the histologically homogenous glioblastoma group could be further subdivided into 4 categories which showed a trend towards prognostic correlation. Thus, this study though preliminary with number of cases being small in some groups, highlights the possible usefulness of combined histological typing, TESTAST grading and in vivo BrdU LI for prognostication of gliomas especially glioblastoma multiforme.",
keywords = "Computer aided grading, Gliomas, Histologic grading, In vivo BrdU LI, Malignancy classification",
author = "Suash Sharma and Karak, {Asis K.} and Rajvir Singh and Mehta, {V. S.} and Chitra Sarkar and Schmitt, {Horst P.}",
year = "1999",
month = "1",
day = "1",
doi = "10.1053/paor.1999.0189",
language = "English (US)",
volume = "5",
pages = "134--141",
journal = "Pathology and Oncology Research",
issn = "1219-4956",
publisher = "Springer Netherlands",
number = "2",

}

TY - JOUR

T1 - A correlative study of gliomas using in vivo bromodeoxyuridine labeling index and computer-aided malignancy grading

AU - Sharma, Suash

AU - Karak, Asis K.

AU - Singh, Rajvir

AU - Mehta, V. S.

AU - Sarkar, Chitra

AU - Schmitt, Horst P.

PY - 1999/1/1

Y1 - 1999/1/1

N2 - An in vivo bromodeoxyuridine (BrdU) labeling index (LI) was estimated in 43 cases of astrocytic tumors and mixed gliomas by one hour intra-operative intravenous infusion at a dose of 200 mg/m 2 and correlated with (a) histological grading using a computer aided malignancy classifier TESTAST- 268; and (b) histological typing using WHO classification. The lowest BrdU LI was seen in pilocytic and gemistocytic astrocytomas followed by astrocytomas, anaplastic astrocytomas and glioblastoma multiforme in that order. Mixed oligoastrocytomas followed the pattern of their astrocytic counterparts. Tumors of similar histological type showed different BrdU LI values especially amongst astrocytomas and glioblastomas. A statistically significant difference in the BrdU LI was also noted between the higher TESTAST grades of astrocytomas (T III and IV) versus the lower TESTAST grades (T II). Unlike earlier reports in literature, in the present study the category of BrdU LI of <1 contained no case of anaplastic astrocytoma or glioblastoma multiforme (TESTAST grades III and IV). Likewise, the category of BrdU LI >5 contained only anaplastic astrocytoma and glioblastoma multiforme (TESTAST grades III and IV). Maximum spread of cases was seen in the BrdU LI category of 1-5, not only in terms of histological types but also TESTAST grades. Thus there appeared to be a positive trend of increasing BrdU LI values both with histological types and increasing TESTAST grades. Further, an interesting observation was that by using a combination of TESTAST grades and BrdU LI, the histologically homogenous glioblastoma group could be further subdivided into 4 categories which showed a trend towards prognostic correlation. Thus, this study though preliminary with number of cases being small in some groups, highlights the possible usefulness of combined histological typing, TESTAST grading and in vivo BrdU LI for prognostication of gliomas especially glioblastoma multiforme.

AB - An in vivo bromodeoxyuridine (BrdU) labeling index (LI) was estimated in 43 cases of astrocytic tumors and mixed gliomas by one hour intra-operative intravenous infusion at a dose of 200 mg/m 2 and correlated with (a) histological grading using a computer aided malignancy classifier TESTAST- 268; and (b) histological typing using WHO classification. The lowest BrdU LI was seen in pilocytic and gemistocytic astrocytomas followed by astrocytomas, anaplastic astrocytomas and glioblastoma multiforme in that order. Mixed oligoastrocytomas followed the pattern of their astrocytic counterparts. Tumors of similar histological type showed different BrdU LI values especially amongst astrocytomas and glioblastomas. A statistically significant difference in the BrdU LI was also noted between the higher TESTAST grades of astrocytomas (T III and IV) versus the lower TESTAST grades (T II). Unlike earlier reports in literature, in the present study the category of BrdU LI of <1 contained no case of anaplastic astrocytoma or glioblastoma multiforme (TESTAST grades III and IV). Likewise, the category of BrdU LI >5 contained only anaplastic astrocytoma and glioblastoma multiforme (TESTAST grades III and IV). Maximum spread of cases was seen in the BrdU LI category of 1-5, not only in terms of histological types but also TESTAST grades. Thus there appeared to be a positive trend of increasing BrdU LI values both with histological types and increasing TESTAST grades. Further, an interesting observation was that by using a combination of TESTAST grades and BrdU LI, the histologically homogenous glioblastoma group could be further subdivided into 4 categories which showed a trend towards prognostic correlation. Thus, this study though preliminary with number of cases being small in some groups, highlights the possible usefulness of combined histological typing, TESTAST grading and in vivo BrdU LI for prognostication of gliomas especially glioblastoma multiforme.

KW - Computer aided grading

KW - Gliomas

KW - Histologic grading

KW - In vivo BrdU LI

KW - Malignancy classification

UR - http://www.scopus.com/inward/record.url?scp=0032791984&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032791984&partnerID=8YFLogxK

U2 - 10.1053/paor.1999.0189

DO - 10.1053/paor.1999.0189

M3 - Article

C2 - 10393366

AN - SCOPUS:0032791984

VL - 5

SP - 134

EP - 141

JO - Pathology and Oncology Research

JF - Pathology and Oncology Research

SN - 1219-4956

IS - 2

ER -